Stocks›Healthcare›GILD

GILD

GILEAD SCIENCES, INC.

NasdaqResearch view

Healthcare · Biological Products, (No Diagnostic Substances) · Large-cap · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$183.1B

Enterprise Value$203.3B

Income$8.5B

Sales$29.4B

Book/sh$18.24

Cash/sh$6.10

Dividend TTM$3.16

Payout47%

Employees—

IPO—

Quick Ratio1.40

Current Ratio1.55

Debt/Eq1.23

EPS (ttm)$6.78

EPS this Y1684.2%

EPS past 3/5Y23.0%

Sales past 3/5Y2.6%

EPS Y/Y TTM1684.2%

Sales Y/Y TTM2.4%

Shs Outstand1.24B

ROA14.4%

ROE37.6%

ROIC20.3%

Gross Margin—

Oper. Margin34.0%

Profit Margin28.9%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$27.3B

2021

$27.3B

2022

$27.1B

2023

$28.8B

2024

$29.4B

2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$27.3B	$27.3B	$27.1B	$28.8B	$29.4B
Gross Profit	—	—	—	—	—
Operating Income	$9.9B	$7.3B	$7.6B	$1.7B	$10.0B
Net Income	$6.2B	$4.6B	$5.7B	$480.0M	$8.5B
Diluted EPS	$4.93	$3.64	$4.50	$0.38	$6.78
Operating Cash Flow	$11.4B	$9.1B	$8.0B	$10.8B	$10.0B
Free Cash Flow	$10.8B	$8.3B	$7.4B	$10.3B	$9.5B